By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Roche today said that the US Food and Drug Administration has approved its pre-analytical instrument, which provides "an integrated primary tube handling solution" for its Cobas automated molecular testing platform.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.